/

Companies / Humacyte

Humacyte

United States

Humacyte is pioneering a platform that enables the investigation, development, and manufacture of bioengineered human tissues and organs

Humacyte, based in United States, has 1 investor on file, among them First In Ventures. Its site was last checked 13 Nov 2026: site answers.

Investors

1 investor on file
InvestorEvidenceType
First In VenturesPortfolio pageVenture capital

In the news

1 headline naming Humacyte

Each headline is matched with evidence and opens on its outlet. Some come through the GDELT Project.

More from First In Ventures

13 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (69%), AI & Machine Learning (19%), Cybersecurity (6%).

See First In Ventures' full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get Humacyte and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when First In Ventures adds a company.

Work email, sign-in link by email. Already have an account? Log in
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/humacyte.com/investors

# also
GET /v1/companies/humacyte.com
GET /v1/companies/humacyte.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing